# Neuraxis, INC: filings

NRXS · NYSE · CIK 1933567 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nrxs.md) · [Financials](/companies/nrxs/financials.md) · [Filings](/companies/nrxs/filings.md) · [Insiders](/companies/nrxs/insiders.md)

## Reports and events: 62 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 45, 8-K 36, 3 15, CORRESP 12, 10-Q 10, S-1/A 8, UPLOAD 8, SCHEDULE 13G/A 6, 424B5 4, FWP 4, 10-K 3, 424B3 3, ARS 3, DEF 14A 3, DEFA14A 3, EFFECT 3, DRS/A 2, DRSLTR 2, NT 10-Q 2, PRE 14A 2, S-3 2, S-3/A 2, S-8 2, SC 13G 2, SC 13G/A 2, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, DRS 1, NT 10-K 1, S-1 1, SC 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 21:00 ET | [8-K](/filings/0001493152-26-047034.md) | 8.01 Other events | 0001493152-26-047034 |
| 2026-08-19 | 21:00 ET | [8-K](/filings/0001493152-26-039247.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001493152-26-039247 |
| 2026-08-11 | 11:00 ET | [10-Q](/filings/0001493152-26-036978.md) | Quarterly report, period 2026-06-30 | 0001493152-26-036978 |
| 2026-07-10 | 11:00 ET | [8-K](/filings/0001493152-26-032769.md) | 8.01 Other events | 0001493152-26-032769 |
| 2026-06-12 | 20:50 ET | [8-K](/filings/0001493152-26-028489.md) | 5.07 Shareholder vote results | 0001493152-26-028489 |
| 2026-05-12 | 11:00 ET | [10-Q](/filings/0001493152-26-022384.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022384 |
| 2026-04-28 | 21:00 ET | [DEF 14A](/filings/0001140361-26-017498.md) | Proxy statement, period 2026-06-10 | 0001140361-26-017498 |
| 2026-04-22 | 20:54 ET | [8-K](/filings/0001493152-26-018580.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018580 |
| 2026-04-21 | 21:28 ET | [8-K](/filings/0001493152-26-018376.md) | 2.02 Results of operations | 0001493152-26-018376 |
| 2026-03-19 | 11:00 ET | [10-K](/filings/0001493152-26-011505.md) | Annual report, period 2025-12-31 | 0001493152-26-011505 |
| 2025-11-10 | 22:01 ET | [10-Q](/filings/0001493152-25-021547.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021547 |
| 2025-10-24 | 12:22 ET | [8-K](/filings/0001493152-25-019186.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-019186 |
| 2025-10-23 | 21:27 ET | [8-K](/filings/0001493152-25-019136.md) | 2.02 Results of operations | 0001493152-25-019136 |
| 2025-09-02 | 13:15 ET | [8-K](/filings/0001641172-25-026158.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-026158 |
| 2025-08-12 | 10:51 ET | [10-Q](/filings/0001641172-25-023100.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023100 |
| 2025-07-03 | 17:20 ET | [8-K](/filings/0001641172-25-017723.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-017723 |
| 2025-06-04 | 20:30 ET | [8-K](/filings/0001641172-25-013632.md) | 5.07 Shareholder vote results | 0001641172-25-013632 |
| 2025-05-28 | 20:15 ET | [8-K](/filings/0001641172-25-012698.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-012698 |
| 2025-05-22 | 10:45 ET | [8-K](/filings/0001641172-25-011973.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-011973 |
| 2025-05-21 | 21:25 ET | [8-K](/filings/0001641172-25-011939.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-011939 |
| 2025-05-12 | 12:05 ET | [10-Q](/filings/0001641172-25-009571.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009571 |
| 2025-04-14 | 13:00 ET | [DEF 14A](/filings/0001140361-25-013641.md) | Proxy statement, period 2025-05-29 | 0001140361-25-013641 |
| 2025-03-20 | 12:00 ET | [10-K](/filings/0001493152-25-010984.md) | Annual report, period 2024-12-31 | 0001493152-25-010984 |
| 2025-01-08 | 14:21 ET | [8-K](/filings/0001493152-25-001323.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-001323 |
| 2024-12-02 | 16:53 ET | [SC 13D](/filings/0001622627-24-000064.md) | Ownership report, active investor | 0001622627-24-000064 |
| 2024-11-25 | 21:30 ET | [8-K](/filings/0001493152-24-047623.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-047623 |
| 2024-11-21 | 22:17 ET | [8-K](/filings/0001493152-24-047196.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-047196 |
| 2024-11-15 | 21:15 ET | [8-K](/filings/0001493152-24-046285.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-046285 |
| 2024-11-12 | 13:15 ET | [8-K](/filings/0001493152-24-044545.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044545 |
| 2024-11-12 | 13:05 ET | [10-Q](/filings/0001493152-24-044538.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044538 |
| 2024-10-18 | 21:05 ET | [8-K](/filings/0001493152-24-041597.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-041597 |
| 2024-09-13 | 20:33 ET | [8-K](/filings/0001493152-24-036212.md) | 3.02 Unregistered sale of equity | 0001493152-24-036212 |
| 2024-08-21 | 20:15 ET | [8-K](/filings/0001493152-24-033444.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-033444 |
| 2024-08-09 | 12:10 ET | [10-Q](/filings/0001493152-24-030875.md) | Quarterly report, period 2024-06-30 | 0001493152-24-030875 |
| 2024-08-09 | 12:05 ET | [8-K](/filings/0001493152-24-030873.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-030873 |
| 2024-07-05 | 20:20 ET | [8-K](/filings/0001493152-24-026362.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-026362 |
| 2024-07-01 | 20:05 ET | [DEF 14A](/filings/0001140361-24-031946.md) | Proxy statement, period 2024-08-15 | 0001140361-24-031946 |
| 2024-05-28 | 20:15 ET | [8-K](/filings/0001493152-24-021615.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-021615 |
| 2024-05-20 | 20:18 ET | [10-Q](/filings/0001493152-24-020692.md) | Quarterly report, period 2024-03-31 | 0001493152-24-020692 |
| 2024-04-16 | 20:33 ET | [10-K](/filings/0001493152-24-014832.md) | Annual report, period 2023-12-31 | 0001493152-24-014832 |
| 2024-04-16 | 20:30 ET | [8-K](/filings/0001493152-24-014829.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-014829 |
| 2024-04-09 | 20:27 ET | [8-K](/filings/0001493152-24-014075.md) | 2.02 Results of operations; 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001493152-24-014075 |
| 2024-03-28 | 20:30 ET | [8-K](/filings/0001493152-24-011761.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-011761 |
| 2024-03-11 | 12:50 ET | [8-K](/filings/0001493152-24-009493.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-009493 |
| 2024-02-15 | 22:00 ET | [8-K](/filings/0001493152-24-006888.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-24-006888 |
| 2024-01-31 | 14:15 ET | [8-K](/filings/0001493152-24-004424.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-004424 |
| 2023-12-19 | 22:00 ET | [8-K](/filings/0001493152-23-045436.md) | 8.01 Other events | 0001493152-23-045436 |
| 2023-11-20 | 22:15 ET | [10-Q](/filings/0001493152-23-042163.md) | Quarterly report, period 2023-09-30 | 0001493152-23-042163 |
| 2023-11-14 | 14:58 ET | [8-K](/filings/0001493152-23-040826.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-040826 |
| 2023-09-22 | 20:16 ET | [10-Q](/filings/0001493152-23-033460.md) | Quarterly report, period 2023-06-30 | 0001493152-23-033460 |

Page 1 of 2. [Older](/companies/nrxs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.